Caricamento...
Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases
BACKGROUND: Therapies for metabolic diseases are numerous, yet improving insulin sensitivity beyond that induced by weight loss remains challenging. Therefore, search continues for novel treatment candidates that can stimulate insulin sensitivity and increase weight loss efficacy in combination with...
Salvato in:
| Pubblicato in: | Mol Metab |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8085567/ https://ncbi.nlm.nih.gov/pubmed/33166741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2020.101109 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|